267
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Statistical Properties of the Design for Simultaneous Global Drug Development Program

, , , &
Pages 1135-1144 | Received 16 Sep 2013, Accepted 25 Sep 2014, Published online: 13 Jul 2015

REFERENCES

  • Casella, G., Berger, R. L. (2002). Statistical Inference (2nd ed.). Pacific Grove, CA: Cengage Learning.
  • Gail, M., Simon, R. (1985). Testing for qualitative interactions between treatment effects and patient subsets. Biometrics 41(2):361–372.
  • Hsiao, C.-F., Xu, J.-Z., Liu, J.-P. (2005). A two-stage design for bridging studies. Journal of Biopharmaceutical Statistics 15:75–83.
  • Huang, Q., Chen, G., Yuan, Z., Lan, K. K. G. (2012). Design and sample size consideration for simultaneous global drug development program. Journal of Biopharmaceutical Statistics 22:1060–73.
  • ICH International Conference on Harmonization Tripartite Guidance E5. (1998). Ethnic factor in the acceptability of foreign data. The US Federal Register 83:31790–31796.
  • Lan, K. K. G., Soo, Y., Siu, C., Wang, M. (2005). The use of weighted Z-tests in medical research. Journal of Biopharmaceutical Statistics 15:625–639.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.